Neural Niche in Promoting Brain Metastatic Tumor Progression
促进脑转移瘤进展的神经生态位
基本信息
- 批准号:10636336
- 负责人:
- 金额:$ 47.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdjuvant TherapyAstrocytesBasic ScienceBehaviorBrainBrain NeoplasmsCancer BiologyCellsCellular Indexing of Transcriptomes and Epitopes by SequencingClinicalComputational BiologyConsequentialismDevelopmentEncephalitisEndothelial CellsEvolutionFutureGeneticGenetic VariationGenomic approachHeterogeneityImage AnalysisImmuneImmune systemImmunosuppressionIn SituIncidenceInfiltrationMalignant NeoplasmsMalignant neoplasm of brainMeasuresMediatingMetastatic malignant neoplasm to brainMetastatic toMolecularNeoplasm MetastasisNeuronsNeurosciencesOrganOutcomePatientsPhenotypePlant RootsPreclinical TestingPrimary NeoplasmProcessRegulationResearchResolutionRoleSignal TransductionSpatial DistributionTherapeuticThree-Dimensional ImageTissue SampleTissue imagingTransforming Growth Factor betaTransgenic MiceTropismbasebrain cellcell typeclinical practiceimaging approachimprovedin vivoinhibitorinnovationinsightinterdisciplinary approachmortalitymouse modelmultidisciplinaryneoplastic cellneuroinflammationnovelpre-clinicalpre-clinical researchpreventrational designrelating to nervous systemresponsesingle cell analysissingle cell sequencingsingle-cell RNA sequencingspatial relationshipspatiotemporalstemstem cellstargeted treatmenttranscriptometranscriptomicstumortumor progression
项目摘要
Project Summary
Title: Neural Niche in Promoting Brain Metastasis Progression
Metastatic progression at the brain is a multi-step, evolutionary process that is accomplished through a
consistent interplay between disseminated tumor cells and brain microenvironment - "the niche". Despite
significantly improved control of primary tumors, the incidence of brain metastasis is increasing! To reduce
cancer mortality, rationally-designed therapeutics, based on a mechanistic understanding of metastasis in at
the unique brain metastatic niche, are urgently needed for brain metastasis patients. What's the brain
metastatic niche? In the brain microenvironment - the niche - is a myriad of diverse cell types that have been
speculated to contribute to the brain tumor and brain metastasis development, including endothelial cells,
astrocytes, neural stem/progenitor cells (NSC hereafter) and increasingly appreciated brain immune cells.
Despite studies of astrocytes, how do the NSC and its progenies respond to brain metastatic colonization and
regulate brain immune landscape and the metastatic outcome has yet to be systematically investigated. Our
preliminary studies have demonstrated that NSC migrates to colonized tumor cells and NSC is functionally
essential for brain metastasis progression. Intriguingly, ample evidence from in the field of neuroscience
suggests an immune suppressive role of NCS during the brain inflammation. Thus, in this proposal, we
hypothesize that NSC and its progenies' brain metastasis tropism and potentially consequential
immunosuppressive activity could contribute to an immune-suppressive metastatic niche, facilitating brain
metastasis progression. In this proposed study, we will use transgenic mouse models and state-of-the-art
genomics and imaging approach to trace and analyze the role of highly heterogeneous cell types involved in
NSC differentiation and immune suppression and their roles in regulating brain metastatic outgrowth. This
collaborative effort integrating multidisciplinary expertise, including cancer biology, neuroscience,
computational biology, allow us to: 1) examine and trace the NSC differentiation response to brain metastasis
at the phenotypical level; 2) visualize and quantitatively measure the behavior of brain metastatic niche cells
and their transcriptome heterogeneity; 3) examine the mechanism by which neural cells derived from NSC
promotes brain metastasis progression. New in-depth mechanistic insights obtained through basic and pre-
clinical innovative research will pave the way to future brain metastases treatments.
项目摘要
标题:促进脑转移进展的神经生态位
大脑的转移进展是一个多步骤的进化过程,通过
播散性肿瘤细胞与脑微环境--“生态位”--之间的持续相互作用。尽管
控制原发肿瘤明显改善,脑转移的发生率正在增加!减少
癌症死亡率,合理设计的治疗方法,基于对肿瘤转移的机制理解
脑转移瘤患者迫切需要独特的脑转移瘤利基。大脑是什么?
转移的利基?在大脑微环境中-利基-是无数不同类型的细胞,它们已经
推测与脑瘤和脑转移的发展有关,包括内皮细胞,
星形胶质细胞,神经干细胞/祖细胞(以下简称NSC)和日益重视的脑免疫细胞。
尽管对星形胶质细胞进行了研究,但神经干细胞及其后代对脑转移定植和
调节大脑免疫格局和转移结果尚未得到系统的研究。我们的
初步研究表明,NSC迁移到定植的肿瘤细胞,并且NSC具有功能
对于脑转移的进展是必不可少的。耐人寻味的是,神经科学领域的大量证据
提示NCS在脑部炎症过程中具有免疫抑制作用。因此,在这项提案中,我们
假设神经干细胞及其子代的脑转移倾向和潜在后果
免疫抑制活性可能有助于免疫抑制转移的利基,促进大脑
转移进展。在这项拟议的研究中,我们将使用转基因小鼠模型和最先进的
基因组学和成像方法追踪和分析高度异质性细胞类型参与的作用
神经干细胞分化和免疫抑制及其在调节脑转移生长中的作用。这
整合多学科专业知识的协作努力,包括癌症生物学、神经科学、
计算生物学,使我们能够:1)检查和追踪神经干细胞对脑转移的分化反应
在表型水平上;2)可视化和定量测量脑转移瘤巢细胞的行为
以及它们转录组的异质性;3)研究神经干细胞分化的机制
促进脑转移的进展。通过基础和预案获得新的深入的机械论见解
临床创新研究将为未来脑转移瘤的治疗铺平道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Siyuan Zhang其他文献
Siyuan Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Siyuan Zhang', 18)}}的其他基金
Neural Niche in Promoting Brain Metastatic Tumor Progression
促进脑转移瘤进展的神经生态位
- 批准号:
10675623 - 财政年份:2021
- 资助金额:
$ 47.98万 - 项目类别:
Prevention of Brain Metastasis Relapse through Modulation of Age-related Gut Microbiota-Immune Cross talk
通过调节与年龄相关的肠道微生物群-免疫串扰来预防脑转移复发
- 批准号:
10287850 - 财政年份:2021
- 资助金额:
$ 47.98万 - 项目类别:
Prevention of Brain Metastasis Relapse through Modulation of Age-related Gut Microbiota-Immune Cross talk
通过调节与年龄相关的肠道微生物群-免疫串扰来预防脑转移复发
- 批准号:
10613161 - 财政年份:2021
- 资助金额:
$ 47.98万 - 项目类别:
Neural Niche in Promoting Brain Metastatic Tumor Progression
促进脑转移瘤进展的神经生态位
- 批准号:
10298995 - 财政年份:2021
- 资助金额:
$ 47.98万 - 项目类别:
Mechanisms of neuroinflammation in brain metastasis progression
神经炎症在脑转移进展中的机制
- 批准号:
10201524 - 财政年份:2018
- 资助金额:
$ 47.98万 - 项目类别:
Mechanisms of neuroinflammation in brain metastasis progression
神经炎症在脑转移进展中的机制
- 批准号:
10642124 - 财政年份:2018
- 资助金额:
$ 47.98万 - 项目类别:
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
(PQD-3) 早期原位转移演化的时空分子研究
- 批准号:
9067260 - 财政年份:2015
- 资助金额:
$ 47.98万 - 项目类别:
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
(PQD-3) 早期原位转移演化的时空分子研究
- 批准号:
8876876 - 财政年份:2015
- 资助金额:
$ 47.98万 - 项目类别:
Dissecting the Role of Src Family Kinases in Breast Cancer Brain Metastasis
剖析 Src 家族激酶在乳腺癌脑转移中的作用
- 批准号:
8091662 - 财政年份:2011
- 资助金额:
$ 47.98万 - 项目类别:
Dissecting the Role of Src Family Kinases in Breast Cancer Brain Metastasis
剖析 Src 家族激酶在乳腺癌脑转移中的作用
- 批准号:
8711359 - 财政年份:2011
- 资助金额:
$ 47.98万 - 项目类别:
相似海外基金
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 47.98万 - 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
- 批准号:
494901 - 财政年份:2023
- 资助金额:
$ 47.98万 - 项目类别:
Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
- 批准号:
10714537 - 财政年份:2023
- 资助金额:
$ 47.98万 - 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
- 批准号:
10588103 - 财政年份:2023
- 资助金额:
$ 47.98万 - 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
- 批准号:
22K09407 - 财政年份:2022
- 资助金额:
$ 47.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
- 批准号:
21KK0287 - 财政年份:2022
- 资助金额:
$ 47.98万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
- 批准号:
10357120 - 财政年份:2022
- 资助金额:
$ 47.98万 - 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
- 批准号:
21K08700 - 财政年份:2021
- 资助金额:
$ 47.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
- 批准号:
437315 - 财政年份:2020
- 资助金额:
$ 47.98万 - 项目类别:
Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
- 批准号:
435603 - 财政年份:2020
- 资助金额:
$ 47.98万 - 项目类别:
Operating Grants














{{item.name}}会员




